247 related articles for article (PubMed ID: 8521383)
21. The proapoptotic effect of hepatitis B virus HBx protein correlates with its transactivation activity in stably transfected cell lines.
Bergametti F; Prigent S; Luber B; Benoit A; Tiollais P; Sarasin A; Transy C
Oncogene; 1999 May; 18(18):2860-71. PubMed ID: 10362257
[TBL] [Abstract][Full Text] [Related]
22. The cysteine residues of the hepatitis B virus onco-protein HBx are not required for its interaction with RNA or with human p53.
de Moura PR; Rui E; de Almeida Gonçalves K; Kobarg J
Virus Res; 2005 Mar; 108(1-2):121-31. PubMed ID: 15681062
[TBL] [Abstract][Full Text] [Related]
23. Mutant p53 but not hepatitis B virus X protein is present in hepatitis B virus-related human hepatocellular carcinoma.
Henkler F; Waseem N; Golding MH; Alison MR; Koshy R
Cancer Res; 1995 Dec; 55(24):6084-91. PubMed ID: 8521397
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis B virus X protein induced expression of the Nur77 gene.
Lee MO; Kang HJ; Cho H; Shin EC; Park JH; Kim SJ
Biochem Biophys Res Commun; 2001 Nov; 288(5):1162-8. PubMed ID: 11700033
[TBL] [Abstract][Full Text] [Related]
25. Expression of HBX, an oncoprotein of hepatitis B virus, blocks reoviral oncolysis of hepatocellular carcinoma cells.
Park EH; Koh SS; Srisuttee R; Cho IR; Min HJ; Jhun BH; Lee YS; Jang KL; Kim CH; Johnston RN; Chung YH
Cancer Gene Ther; 2009 May; 16(5):453-61. PubMed ID: 19096445
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis B virus X protein transcription activation domains are neither required nor sufficient for cell transformation.
Gottlob K; Pagano S; Levrero M; Graessmann A
Cancer Res; 1998 Aug; 58(16):3566-70. PubMed ID: 9721862
[TBL] [Abstract][Full Text] [Related]
27. Functional interactions between p53 and the TFIIH complex are affected by tumour-associated mutations.
Léveillard T; Andera L; Bissonnette N; Schaeffer L; Bracco L; Egly JM; Wasylyk B
EMBO J; 1996 Apr; 15(7):1615-24. PubMed ID: 8612585
[TBL] [Abstract][Full Text] [Related]
28. Progressive changes in hepatoma cells stably transfected with hepatitis B virus X gene.
Ye L; Dong N; Wang Q; Xu Z; Cai N; Wang H; Zhang X
Intervirology; 2008; 51(1):50-8. PubMed ID: 18334850
[TBL] [Abstract][Full Text] [Related]
29. Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues.
Tu H; Bonura C; Giannini C; Mouly H; Soussan P; Kew M; Paterlini-Bréchot P; Bréchot C; Kremsdorf D
Cancer Res; 2001 Nov; 61(21):7803-10. PubMed ID: 11691796
[TBL] [Abstract][Full Text] [Related]
30. Human hepatitis B virus X protein promotes cell proliferation and inhibits cell apoptosis through interacting with a serine protease Hepsin.
Zhang JL; Zhao WG; Wu KL; Wang K; Zhang X; Gu CF; Li Y; Zhu Y; Wu JG
Arch Virol; 2005 Apr; 150(4):721-41. PubMed ID: 15614436
[TBL] [Abstract][Full Text] [Related]
31. [Pro-apoptotic function of hepatitis B virus X protein].
Kim KH
Korean J Hepatol; 2010 Jun; 16(2):112-22. PubMed ID: 20606495
[TBL] [Abstract][Full Text] [Related]
32. Activation of the insulin-like growth factor II transcription by aflatoxin B1 induced p53 mutant 249 is caused by activation of transcription complexes; implications for a gain-of-function during the formation of hepatocellular carcinoma.
Lee YI; Lee S; Das GC; Park US; Park SM; Lee YI
Oncogene; 2000 Aug; 19(33):3717-26. PubMed ID: 10949925
[TBL] [Abstract][Full Text] [Related]
33. The transactivation and p53-interacting functions of hepatitis B virus X protein are mutually interfering but distinct.
Lin Y; Nomura T; Yamashita T; Dorjsuren D; Tang H; Murakami S
Cancer Res; 1997 Nov; 57(22):5137-42. PubMed ID: 9371515
[TBL] [Abstract][Full Text] [Related]
34. Analysis of the tumorigenicity of the X gene of hepatitis B virus in a nontransformed hepatocyte cell line and the effects of cotransfection with a murine p53 mutant equivalent to human codon 249.
Oguey D; Dumenco LL; Pierce RH; Fausto N
Hepatology; 1996 Nov; 24(5):1024-33. PubMed ID: 8903370
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B virus X protein sensitizes hepatocellular carcinoma cells to cytolysis induced by E1B-deleted adenovirus through the disruption of p53 function.
Hsieh JL; Wu CL; Lee CH; Shiau AL
Clin Cancer Res; 2003 Jan; 9(1):338-45. PubMed ID: 12538486
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx.
Sirma H; Giannini C; Poussin K; Paterlini P; Kremsdorf D; Bréchot C
Oncogene; 1999 Aug; 18(34):4848-59. PubMed ID: 10490818
[TBL] [Abstract][Full Text] [Related]
37. Putative tumor suppressor YueF affects the functions of hepatitis B virus X protein in hepatoma cell apoptosis and p53 expression.
Huang J; Wu K; Zhang J; Si W; Zhu Y; Wu J
Biotechnol Lett; 2008 Feb; 30(2):235-42. PubMed ID: 18000758
[TBL] [Abstract][Full Text] [Related]
38. Expression of integrated hepatitis B virus X variants in human hepatocellular carcinomas and its significance.
Chen WN; Oon CJ; Leong AL; Koh S; Teng SW
Biochem Biophys Res Commun; 2000 Oct; 276(3):885-92. PubMed ID: 11027564
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis B virus-X protein recruits histone deacetylase 1 to repress insulin-like growth factor binding protein 3 transcription.
Shon JK; Shon BH; Park IY; Lee SU; Fa L; Chang KY; Shin JH; Lee YI
Virus Res; 2009 Jan; 139(1):14-21. PubMed ID: 18948152
[TBL] [Abstract][Full Text] [Related]
40. Functional characterization of hepatitis B virus X protein based on the inhibition of tumorigenesis in nude mice injected with CCL13-HBx cells.
Kuo CY; Wang JC; Hsu SL; Hwang GY
Intervirology; 2008; 51(4):253-60. PubMed ID: 18824872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
